Snowden Capital Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$477K Sell
5,258
-218
-4% -$20K 0.01% 820
2025
Q4
$494K Sell
5,476
-61
-1% -$5.78K 0.01% 814
2025
Q3
$547K Sell
5,537
-98
-2% -$9.71K 0.01% 735
2025
Q2
$515K Buy
5,635
+674
+14% +$65.2K 0.02% 751
2025
Q1
$563K Buy
4,961
+99
+2% +$10.6K 0.02% 690
2024
Q4
$515K Buy
4,862
+2,227
+85% +$239K 0.02% 761
2024
Q3
$285K Sell
2,635
-676
-20% -$73.8K 0.01% 1017
2024
Q2
$360K Sell
3,311
-369
-10% -$43.5K 0.01% 895
2024
Q1
$487K Sell
3,680
-145
-4% -$18.1K 0.02% 775
2023
Q4
$466K Sell
3,825
-374
-9% -$41.7K 0.02% 727
2023
Q3
$471K Sell
4,199
-3,166
-43% -$402K 0.02% 681
2023
Q2
$1.07M Sell
7,365
-825
-10% -$112K 0.04% 441
2023
Q1
$1.06M Buy
8,190
+18
+0.2% +$2.26K 0.04% 444
2022
Q4
$1.04M Buy
8,172
+750
+10% +$87K 0.04% 440
2022
Q3
$775K Buy
7,422
+1,620
+28% +$178K 0.04% 493
2022
Q2
$609K Buy
5,802
+768
+15% +$91.1K 0.03% 553
2022
Q1
$643K Buy
5,034
+3,613
+254% +$436K 0.03% 548
2021
Q4
$175K Sell
1,421
-1,461
-51% -$191K 0.01% 696
2021
Q3
$410K Buy
2,882
+57
+2% +$8.38K 0.02% 589
2021
Q2
$441K Buy
2,825
+29
+1% +$4.7K 0.02% 579
2021
Q1
$435K Buy
2,796
+1,245
+80% +$193K 0.02% 526
2020
Q4
$232K Buy
+1,551
New +$219K 0.02% 593

Other funds holding ZBH

Snowden Capital Advisors's ZBH Position: Q1 2026 in Review

Snowden Capital Advisors reduced its Zimmer Biomet (ZBH) stake by 4% in Q1 2026, selling an estimated $20K and leaving 5,258 shares worth $477K. The position accounts for 0.01% of the portfolio, ranked #820.

Snowden Capital Advisors first reported a position in ZBH in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.07M in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Snowden Capital Advisors held 5,258 shares of Zimmer Biomet worth $477K as of Q1 2026.
  • Snowden Capital Advisors sold 218 Zimmer Biomet shares in Q1 2026, an estimated $20K.
  • Zimmer Biomet made up 0.01% of Snowden Capital Advisors's portfolio in Q1 2026, its #820 holding.
  • Snowden Capital Advisors first reported a position in Zimmer Biomet in Q4 2020 and has held it in 22 quarters since.
  • Snowden Capital Advisors's Zimmer Biomet position peaked at $1.07M in Q2 2023.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Snowden Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.